Screening for Occult Cancer in Patients with Venous Thromboembolism.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2020 – Feb 2024Where it's discussed
-
X / Twitter38 posts
-
YouTube2 videos
AI synopsis
What people are saying
Several posts mention the article's focus on limited screening methods for occult cancer in VTE patients, with some discussing the balance between thoroughness and practicality. The tone is mostly informational, using phrases like 'past, present, and future' and referencing PubMed to underline the article's scientific basis. Overall, the discussions reflect a cautious curiosity, recognizing the clinical relevance without strong opinions about revolutionary change.
Posts express a neutral stance, with some recognizing the article's findings while others show hesitation or open-mindedness, reflecting mixed opinions.
Discussions show mild curiosity, with comments emphasizing the relevance of screening practices but not delving deeply into controversial or complex issues.
Comments briefly reference the article and its implications, indicating a basic level of engagement without extensive critique or analysis.
The overall conversation suggests moderate perception of impact, with discussions acknowledging the importance but not emphasizing a transformative effect on clinical practice.
Abstract in brief
- Unprovoked venous thromboembolism (VTE) can sometimes be the first indicator of hidden (occult) cancer, with about 5% of cases being diagnosed within a year.
- While screening for occult cancer in these patients seems beneficial to reduce cancer-related death and improve quality of life, extensive screening methods like CT scans haven't shown a clear benefit in improving outcomes based on clinical trials.
- Current guidelines recommend only limited screening—such as medical history, physical exams, basic lab tests, chest X-ray, and age/gender-specific cancer tests—rather than more aggressive investigations, for detecting hidden cancers in VTE patients.
Top posts
Most liked on X and BlueskyRT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
All mentions
Timing and Methods for Thrombophilia Screening in Clinical Practice
This episode discusses when and how to perform effective thrombophilia testing in laboratories. It features insights from experts on pragmatic approaches to thrombophilia assessment, highlighting current guidelines and…
Thrombophilia Testing: When and How to Conduct It Effectively
This episode discusses the appropriate timing and methods for thrombophilia testing based on international standards, featuring expert insights from Franois Depasse.
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
RT @gabi_puchepalao:
PubMed_ Screening for Occult Cancer in Patients with Venous Thromboembolism: Past, Present, and Future. https://t.co/t68fhrNrJw
GP
US
JC
SR
HM
JQ
RL
D
F
EL
PB
MB
L
AC
VH
D
RS
MG
LC
JJ
CM
R
?
A
M
PM
NS
CL
V
CT
JP
AD
C
MG
DA
U
C